New agenda of the Aemps: management by objectives and supply plan

Source: Redaccionmedica.com The Spanish Agency of Medicines and Health Products has presented its Strategic Plan 2019-2022 that includes a total of 11 measures that aim to face the challenges and strengthen the entity during the next four years. Specifically, the Aemps has defined five strategic objectives to achieve through this plan. The 11 measures developed […]

Clinical trials provide a positive economic impact on the NHS

Source: Immedicohospitalario.es The carrying out of clinical trials in Spanish hospitals and research centers has very positive consequences for the agents involved. For the health system, because the trials attract economic investments for the centers. For health professionals, because they add reputation and experience to complement their work with the researcher. For the pharmaceutical industry, […]

Spain, before a historic opportunity in the commitment to clinical trials

Source: Farmaindustria.es Have highly qualified, motivated and experienced professionals, have the ability to achieve patient participation and have processes digitized as electronic medical records. These are some of the main requirements that must be met by hospitals seeking to become centers of excellence in clinical research, according to representatives of Farmaindustria on Thursday in the […]

Roche launches a clinical trials platform focused on the needs of patients

Source: actasanitaria.com The pharmaceutical company Roche has announced the launch of a new platform for clinical trials that is designed with the needs of patients throughout the process of their disease and that offers informative information on clinical research. Through this new tool, Patients can access scientific and up-to-date information about the clinical trials carried […]

The Association of Pharmaceutical Industry discusses counterfeit medicines

Source: actasanitaria.com On March 14, the 39th Symposium of the Spanish Association of Pharmaceutical Industry (AEFI) began in Barcelona, ??under the theme ‘Tracings and in contact with new challenges’, a meeting that will be attended by close 350 representatives of the different health administrations and industry, to discuss issues such as counterfeit medicines and novelties […]

Promote R & D, ensure access and measure results, keys to the future in oncological drugs

Source: actasanitaria.com During a debate at the 7th Forum of the Foundation for Excellence and Quality of Oncology (ECO) held in Madrid, the president of Farmaindustria, Martín Sellés, has pointed out as a key to the future in oncological medicines the promotion of R & D, ensure access and measure health outcomes. According to the […]

The pharmaceutical industry has doubled its investment in clinical research in Spain since 2005

Source: farmaindustria.es In less than three decades Spain has experienced an unprecedented advance in biomedical research, to be placed in the group of countries with better conditions for the future to host international biomedical R & D projects. This has been highlighted this Tuesday in Madrid during the XII Annual Conference of the Biomedical Research […]

The AEMPS explains how to apply for the temporary exemption for batch control in the United Kingdom

Source: actasanitaria.com The Spanish Agency for Medicines and Healthcare Products (AEMPS) has informed about the possibility of requesting the temporary exemption from the obligation to carry out batch control analyzes in entities located in the European Union (EU) after leaving the United Kingdom , an informative note that describes the procedure, terms and conditions to […]

First criteria to offer T-CAR therapies; Health figure “between 5 and 7” reference hospitals

Source: diariomedico.com This Tuesday the institutional working group of the plan on T-CAR therapies in the SNS meets. At the entrance of the meeting, the Minister of Health, María Luisa Carcedo, has made an estimate of the number of reference hospitals with which, from the outset, Spain could count on to offer T-CAR therapies: “There […]

Javier Urzay, deputy director of Farmaindustria: “We want to turn Spain into one of the most attractive places in the world to do biomedical research”

Source: Farmaindustria.es “In this country we have a first-line healthcare system, well-trained health professionals, excellent research centers, committed patient organizations and pioneering legislation in Europe. Along with the commitment of pharmaceutical companies, the goal of all is to make Spain one of the most attractive places in the world to do biomedical research. ” This […]